Gene Symbol | Pearson Correlation Coefficient |
---|---|
TLR8 | 0.867 |
ARL11 | 0.854 |
TLR1 | 0.843 |
ARHGAP15 | 0.842 |
NOD2 | 0.835 |
MS4A4A | 0.829 |
KYNU | 0.828 |
DAPP1 | 0.825 |
TFEC | 0.824 |
GPR65 | 0.816 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
KCNIP3 | -0.405 |
CPLX3 | -0.4 |
HRH3 | -0.386 |
WNT7A | -0.374 |
CHRNA4 | -0.373 |
ASPDH | -0.37 |
WFDC1 | -0.368 |
ATP2C2 | -0.366 |
C15orf59 | -0.364 |
KCNK4 | -0.359 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased expression of FPR3 mRNA | 19191707 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of FPR3 mRNA | 21420995 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of FPR3 gene | 27153756 |
D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of FPR3 mRNA | 24449571 |
C483161 | beta-hydroxy simvastatin acid | beta-hydroxy simvastatin acid results in increased expression of FPR3 mRNA | 18192240 |
C006780 | bisphenol A | bisphenol A results in decreased expression of FPR3 mRNA | 25181051 |
D003474 | Curcumin | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of FPR3 mRNA] | 18200517 |
D002117 | Calcitriol | Calcitriol results in decreased expression of FPR3 mRNA | 26485663 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of FPR3 mRNA | 21831303 |
D009532 | Nickel | Nickel results in increased expression of FPR3 mRNA | 25583101 |
C029938 | nickel sulfate | nickel sulfate results in increased expression of FPR3 mRNA | 22714537 |
D014302 | Trinitrobenzenesulfonic Acid | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of FPR3 mRNA] | 18200517 |
D014302 | Trinitrobenzenesulfonic Acid | Trinitrobenzenesulfonic Acid results in increased expression of FPR3 mRNA | 18200517 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0004875 | complement receptor activity | - | IBA | 21873635 |
GO:0004930 | G-protein coupled receptor activity | - | IBA | 21873635 |
GO:0004982 | N-formyl peptide receptor activity | - | IBA | 21873635 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0002430 | complement receptor mediated signaling pathway | - | IBA | 21873635 |
GO:0006954 | inflammatory response | - | IBA | 21873635 |
GO:0007165 | signal transduction | - | TAS | 8198572 |
GO:0007186 | G-protein coupled receptor signaling pathway | - | TAS | - |
GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway | - | IBA | 21873635 |
GO:0007204 | positive regulation of cytosolic calcium ion concentration | - | IBA | 21873635 |
GO:0050900 | leukocyte migration | - | IBA | 21873635 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005886 | plasma membrane | - | TAS | - |
GO:0016021 | integral component of membrane | - | TAS | 8198572 |
KEGG ID | KEGG Term |
---|---|
hsa04080 | Neuroactive ligand-receptor interaction |
hsa05150 | Staphylococcus aureus infection |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-162582 | Signal Transduction | TAS |
R-HSA-372790 | Signaling by GPCR | TAS |
R-HSA-373076 | Class A/1 (Rhodopsin-like receptors) | TAS |
R-HSA-375276 | Peptide ligand-binding receptors | TAS |
R-HSA-388396 | GPCR downstream signalling | TAS |
R-HSA-418594 | G alpha (i) signalling events | TAS |
R-HSA-444473 | Formyl peptide receptors bind formyl peptides and many other ligands | TAS |
R-HSA-500792 | GPCR ligand binding | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
29544524 | Defective formyl peptide receptor 2/3 and annexin A1 expressions associated with M2a polarization of blood immune cells in patients with chronic obstructive pulmonary disease. (2018 Mar 15) | Chen YC | J Transl Med |